{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:14:50Z","timestamp":1792440890523,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> To investigate the effectiveness and recurrence risk of different ovulation stimulation protocols in early-stage endometrioid endometrial cancer (EEC) and atypical endometrial hyperplasia (AEH) patients after successful fertility preserving treatment.<\/jats:p><jats:p><jats:bold>Design:<\/jats:bold> A retrospective review of clinical files between June 2012 and July 2018.<\/jats:p><jats:p><jats:bold>Setting:<\/jats:bold> University hospital.<\/jats:p><jats:p><jats:bold>Patients:<\/jats:bold> Ninety seven women (74 AEH and 23 early-stage EEC patients) underwent <jats:italic>in vitro<\/jats:italic> fertilization (IVF) and frozen-thawed embryo transfer (FET) after successful fertility preserving treatment. All patients received megestrol acetate which was initiated immediately after AEH or EEC diagnosis by hysteroscopy. Fertility treatment was initiated after confirmation of complete response by two consecutive hysteroscopic evaluations and endometrium biopsy in a 3-month interval. Women with tubal factors underwent IVF treatment directly. Women who failed to conceive spontaneously within 12 months or after other infertility treatments like ovulation induction for 6 consecutive months or 2 consecutive artificial insemination failures were also offered IVF treatment.<\/jats:p><jats:p><jats:bold>Main Outcome Measure (s):<\/jats:bold> The clinical and laboratory embryo data, clinical pregnancy outcomes and endometrial disease recurrence rates.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Compared with the standard regimen group, the good-quality embryo rate was higher in progestin primed ovarian stimulation (PPOS) regimen group (<jats:italic>P<\/jats:italic> = 0.034). Univariate analysis showed significant differences in age (<jats:italic>P<\/jats:italic> = 0.033), treatment time of endometrial lesions (<jats:italic>P<\/jats:italic> &amp;lt; 0.001), and duration of Gn treatment (<jats:italic>P<\/jats:italic> = 0.018) between the recurrent and non-recurrent groups. In the adjusted model of multivariate logistic regression analysis, the age (<jats:italic>P<\/jats:italic> = 0.014) at ovulation induction and treatment time of endometrial lesions (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) were significantly correlated with the recurrence of endometrial disease.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The PPOS protocol is a feasible and safe strategy to stimulate ovulation during IVF after fertility preservation therapy, and the age at ovulation induction and treatment time of endometrial lesions are two stable predictors of recurrence in endometrial diseases.<\/jats:p>","DOI":"10.3389\/fmed.2021.581927","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T06:57:48Z","timestamp":1627369068000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["PPOS Protocol Effectively Improves the IVF Outcome Without Increasing the Recurrence Rate in Early Endometrioid Endometrial Cancer and Atypical Endometrial Hyperplasia Patients After Fertility Preserving Treatment"],"prefix":"10.3389","volume":"8","author":[{"given":"Jiazhou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiandong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejogrb.2016.05.049","article-title":"Risk of coexisting endometrial carcinoma in case of atypical endometrial hyperplasia diagnosed on total hysteroscopic resection","volume":"203","author":"Pivano","year":"2016","journal-title":"Eur J Obst Gynecol Reprod Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.3802\/jgo.2018.29.e21","article-title":"Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?","volume":"29","author":"Yamagami","year":"2018","journal-title":"J Gynecol Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jmig.2018.07.001","article-title":"Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study","volume":"26","author":"Giampaolino","year":"2019","journal-title":"J Minim Invasive Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","article-title":"Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia","volume":"14","author":"Inoue","year":"2016","journal-title":"Reprod Biol Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12916-019-1354-1","article-title":"Effect of body mass index on pregnancy outcomes in a freeze-all policy: an analysis of 22,043 first autologous frozen-thawed embryo transfer cycles in China","volume":"17","author":"Zhang","year":"2019","journal-title":"BMC Med."},{"key":"B6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-319-52210-4_17","article-title":"Assisted reproductive technology: clinical aspects","volume-title":"Clinical Reproductive Medicine and Surgery","author":"Mahany","year":"2017"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2147\/DDDT.S210228","article-title":"Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Design Dev Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.fertnstert.2007.01.058","article-title":"Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma","volume":"88","author":"Elizur","year":"2007","journal-title":"Fertil Steril."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S699","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative treatment with progestin and pregnancy outcomes in endometrial cancer","volume":"107","author":"Hahn","year":"2009","journal-title":"Int J Gynecol Cancer Official J Int Gynecol Cancer Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ygyno.2019.01.014","article-title":"Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer","volume":"153","author":"Yang","year":"2019","journal-title":"Gynecol Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids."},{"key":"B12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fendo.2018.00690","article-title":"Mid-luteal 17-OH progesterone levels in 614 women undergoing IVF-treatment and fresh embryo transfer\u2013daytime variation and impact on live birth rates","volume":"9","author":"Thomsen","year":"2018","journal-title":"Front Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/BF01133388","article-title":"A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality","volume":"3","author":"Cummins","year":"1986","journal-title":"J In Vitro Fert Embryo Transf."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","article-title":"Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril."},{"key":"B15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.repbio.2020.08.002","article-title":"Effects of euploid blastocyst morphological development on reproductive outcomes","volume":"20","author":"Peng","year":"2020","journal-title":"Reprod Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11596-017-1746-4","article-title":"Predictive value of initial serum human chorionic gonadotropin levels for pregnancies after single fresh and frozen blastocyst transfer","volume":"37","author":"Zhao","year":"2017","journal-title":"J Huazhong Univ Sci Technolog Med Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.fertnstert.2005.01.139","article-title":"Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation","volume":"84","author":"Malmusi","year":"2005","journal-title":"Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/humrep\/deg021","article-title":"Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles","volume":"18","author":"Hwang","year":"2003","journal-title":"Hum Reprod."},{"key":"B19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4274\/tjod.45656","article-title":"The relationship between estradiol-progesterone alterations after ovulation trigger and treatment success in intrauterine insemination cycles","volume":"13","author":"Kutlu","year":"2016","journal-title":"Turk J Obst Gynecol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1262\/jrd.2011-012","article-title":"Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells","volume":"58","author":"Matsuda","year":"2012","journal-title":"J Reprod Dev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3978\/j.issn.2305-5839.2015.04.09","article-title":"Comparison of different stimulation protocols used in in vitro fertilization: a review","volume":"3","author":"Shrestha","year":"2015","journal-title":"Ann Transl Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.fertnstert.2016.07.1068","article-title":"Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist","volume":"106","author":"Lu","year":"2016","journal-title":"Fertil Steril."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.ygyno.2008.07.056","article-title":"Sparing fertility in young patients with endometrial cancer","volume":"111","author":"Chiva","year":"2008","journal-title":"Gynecol Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000209324","article-title":"Fertility-sparing in endometrial cancer","volume":"67","author":"Tangjitgamol","year":"2009","journal-title":"Gynecol Obstet Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/humupd\/dmi006","article-title":"Fertility and ageing","volume":"11","author":"Baird","year":"2005","journal-title":"Hum Reprod Update."},{"key":"B28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/humrep\/deq014","article-title":"Gene expression profiles of single human mature oocytes in relation to age","volume":"25","author":"Grondahl","year":"2010","journal-title":"Hum Reprod."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.581927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T06:57:52Z","timestamp":1627369072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.581927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":28,"alternative-id":["10.3389\/fmed.2021.581927"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.581927","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"article-number":"581927"}}